BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37183816)

  • 1. Prostate organoids: emerging experimental tools for translational research.
    Beshiri M; Agarwal S; Yin JJ; Kelly K
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
    Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K
    Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182
    [No Abstract]   [Full Text] [Related]  

  • 3. A synopsis of prostate organoid methodologies, applications, and limitations.
    Gleave AM; Ci X; Lin D; Wang Y
    Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer research using organoid technology.
    Kretzschmar K
    J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
    Seidlitz T; Stange DE
    Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.
    Zhang D; Lin K; Lu Y; Rycaj K; Zhong Y; Chao HP; Calhoun-Davis T; Shen J; Tang DG
    Stem Cells Transl Med; 2017 Mar; 6(3):748-760. PubMed ID: 28297567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
    Servant R; Garioni M; Vlajnic T; Blind M; Pueschel H; Müller DC; Zellweger T; Templeton AJ; Garofoli A; Maletti S; Piscuoglio S; Rubin MA; Seifert H; Rentsch CA; Bubendorf L; Le Magnen C
    J Pathol; 2021 Aug; 254(5):543-555. PubMed ID: 33934365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies.
    Hepburn AC; Sims CHC; Buskin A; Heer R
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.
    Waseem M; Wang BD
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobanking of human gut organoids for translational research.
    Perrone F; Zilbauer M
    Exp Mol Med; 2021 Oct; 53(10):1451-1458. PubMed ID: 34663935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate organoid technology - the new POT of gold in prostate stem cell and cancer research.
    Mai CW; Shu Y; Cheong SK; Chua CW
    Sheng Li Xue Bao; 2021 Apr; 73(2):181-196. PubMed ID: 33903880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single luminal epithelial progenitors can generate prostate organoids in culture.
    Chua CW; Shibata M; Lei M; Toivanen R; Barlow LJ; Bergren SK; Badani KK; McKiernan JM; Benson MC; Hibshoosh H; Shen MM
    Nat Cell Biol; 2014 Oct; 16(10):951-61, 1-4. PubMed ID: 25241035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
    Kumari R; Xu X; Li HQ
    Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses.
    Pappas KJ; Choi D; Sawyers CL; Karthaus WR
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31710046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity and complexity of the prostate epithelium: New findings from single-cell RNA sequencing studies.
    Crowley L; Shen MM
    Cancer Lett; 2022 Jan; 525():108-114. PubMed ID: 34728312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells.
    Usui T; Sakurai M; Nishikawa S; Umata K; Nemoto Y; Haraguchi T; Itamoto K; Mizuno T; Noguchi S; Mori T; Iwai S; Nakagawa T; Yamawaki H; Ohama T; Sato K
    Cancer Sci; 2017 Dec; 108(12):2383-2392. PubMed ID: 29024204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multipotent luminal progenitor cells in human prostate organoid cultures.
    Karthaus WR; Iaquinta PJ; Drost J; Gracanin A; van Boxtel R; Wongvipat J; Dowling CM; Gao D; Begthel H; Sachs N; Vries RGJ; Cuppen E; Chen Y; Sawyers CL; Clevers HC
    Cell; 2014 Sep; 159(1):163-175. PubMed ID: 25201529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Organoid Assay for Long-Term Maintenance and Propagation of Mouse Prostate Luminal Epithelial Progenitors and Cancer Cells.
    Shu Y; Chua CW
    Methods Mol Biol; 2019; 1940():231-254. PubMed ID: 30788830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
    Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
    SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.